Cargando…
Apoptosis and non-alcoholic fatty liver diseases
The number of patients with nonalcoholic fatty liver diseases (NAFLD) including nonalcoholic steatohepatitis (NASH), has been increasing. NASH causes cirrhosis and hepatocellular carcinoma (HCC) and is one of the most serious health problems in the world. The mechanism through which NASH progresses...
Autores principales: | Kanda, Tatsuo, Matsuoka, Shunichi, Yamazaki, Motomi, Shibata, Toshikatsu, Nirei, Kazushige, Takahashi, Hiroshi, Kaneko, Tomohiro, Fujisawa, Mariko, Higuchi, Teruhisa, Nakamura, Hitomi, Matsumoto, Naoki, Yamagami, Hiroaki, Ogawa, Masahiro, Imazu, Hiroo, Kuroda, Kazumichi, Moriyama, Mitsuhiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6034146/ https://www.ncbi.nlm.nih.gov/pubmed/29991872 http://dx.doi.org/10.3748/wjg.v24.i25.2661 |
Ejemplares similares
-
Possible association of arrestin domain-containing protein 3 and progression of non-alcoholic fatty liver disease
por: Ogawa, Masahiro, et al.
Publicado: (2019) -
Retreatment of patients with treatment failure of direct-acting antivirals: Focus on hepatitis C virus genotype 1b
por: Kanda, Tatsuo, et al.
Publicado: (2017) -
Persistent Hepatic Inflammation Plays a Role in Hepatocellular Carcinoma After Sustained Virological Response in Patients with HCV Infection
por: Nirei, Kazushige, et al.
Publicado: (2018) -
Steatosis influences the clinical profiles and long-term outcomes of interferon-treated chronic hepatitis C and liver cirrhosis patients
por: Nirei, Kazushige, et al.
Publicado: (2017) -
Different Mechanisms of Action of Regorafenib and Lenvatinib on Toll-Like Receptor-Signaling Pathways in Human Hepatoma Cell Lines
por: Sasaki, Reina, et al.
Publicado: (2020)